Carbazeran
CAS: 70724-25-3
Ref. 3D-FC19687
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Product Information
- N-Ethylcarbamic acid 1-(6,7-dimethoxy-1-phthalazinyl)-4-piperidinyl esterEthylcarbamic acid 1-(6,7-dimethoxy-1-phthalazinyl)-4-pipe ridinyl esterUK 31557
- 1-(6,7-Dimethoxyphthalazin-1-yl)piperidin-4-yl ethylcarbamate
- 70724-25-3
- Carbamic acid, ethyl-, 1-(6,7-dimethoxy-1-phthalazinyl)-4-piperidinyl ester
- Ethylcarbamic Acid 1-(6,7-Dimethoxy-1-phthalazinyl)-4-piperidinyl Ester
- Uk 31557
- carbamic acid, N-ethyl-, 1-(6,7-dimethoxy-1-phthalazinyl)-4-piperidinyl ester
Carbazeran is a novel pharmacological agent that is being developed for the treatment of bowel disease. It inhibits the enzyme dipeptidyl peptidase-4 (DPP-4) and has been shown to have beneficial effects in vitro on human cells and in vivo models of heart failure. DPP-4 is responsible for breaking down the hormone glucagon-like peptide 1 (GLP-1), which has been shown to have beneficial effects on inflammatory bowel disease. Carbazeran binds to DPP-4, thereby inhibiting its activity, and prevents the breakdown of GLP-1. This leads to an increase in GLP-1 levels and an improvement in inflammatory bowel disease symptoms.
Chemical properties
Technical inquiry about: 3D-FC19687 Carbazeran
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.